Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Jerusalem Daily Journal.
Press releases published on May 19, 2025

BiomX CEO Jonathan Solomon to Present at Biomed Israel 2025 Conference
NESS ZIONA, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that …

Duke Robotics Strengthens Global Growth Strategy with Appointment of Yuval Hogeg as International Business Development Director
FT. LAUDERDALE, FL, May 19, 2025 (GLOBE NEWSWIRE) -- Duke Robotics Corp. (OTCQB:DUKR) (“Duke Robotics” or the “Company”), a leader in advanced robotics technology and autonomous drone solutions, today announced the appointment of Mr. Yuval Hogeg as the …

Foresight Signs Commercialization Agreement with Global Rail Tech Provider for up to $12 Million in Revenue Starting in 2026
The agreement with StreamRail, a Chinese leader in rail transit technologies, aims to enhance safety and operational efficiency for urban rail transit systems Ness Ziona, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq …

Gilat Reports First Quarter 2025 Results
Revenues Increased 21% Year-over-Year with Adjusted EBITDA of $7.6 Million Reiterates Guidance for 2025 PETAH TIKVA, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite …

Teva Announces $2,000,000,000 (Equivalent) Debt Tender Offers For Notes Due 2026-2031
TEL AVIV, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today that it has commenced tender offers (the “Offers”) to purchase for cash for a combined aggregate purchase price (exclusive …

Teva Announces Launch of $2,000,000,000 (Equivalent) Offering of Senior Notes
TEL AVIV, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today its intention to issue $2,000,000,000 (equivalent) of senior notes through its special purpose finance subsidiaries. Teva …

Formula Systems Files Annual Report on Form 20-F for the Year Ended December 31, 2024
OR YEHUDA, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Formula Systems (1985) Ltd. (Nasdaq and TASE: FORTY) (“Formula” or the “Company”), a global information technology group engaged, through its subsidiaries and affiliates, in providing software consulting …